FDA label 4ebb446e-0ca4-44cb-a835-d3f989e8de88

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

SPL set ID
767aa369-d356-46d4-b9dc-db5342c4d32c
SPL ID
4ebb446e-0ca4-44cb-a835-d3f989e8de88
Version
3
Effective date
2016-05-18
Source export date
2026-09-28
Source partition
7
Source file
https://download.open.fda.gov/drug/label/drug-label-0007-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/bb1af06e95bcf9567b07e56fcf3a03c0cac3c7c82ff89d4c970881174949e5b7/drug-label-0007-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 05:50:26

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings FEDERAL LAW PROHIBITS DISPENISNG WITHOUT A PRESCRIPTION.

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 1 matching rows.

adverse reactions

ADVERSE REACTIONS: The most severe adverse effectis hyperkalemia which may casue cardiac arrhytmias, heart block, and fall in blood pressure. Flaccid paralysis, mental confussion, lislessness, paresthesias of the extremities, and weakness of the legs may be present. Nausea, vomiting, and diarreha are best avoided by dilutingthe preparation as specified in DOSAGE AND ADMINISTRATION, and taking with food.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.